Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Merck
Novartis
Johnson and Johnson
Colorcon
Dow
Daiichi Sankyo
Fuji
Mallinckrodt
Cipla

Generated: August 17, 2017

DrugPatentWatch Database Preview

FORTAZ Drug Profile

« Back to Dashboard

Which patents cover Fortaz, and what generic Fortaz alternatives are available?

Fortaz is a drug marketed by Teligent and is included in two NDAs.

The generic ingredient in FORTAZ is ceftazidime sodium. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ceftazidime sodium profile page.

Summary for Tradename: FORTAZ

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list18
Patent Applications: see list5,281
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FORTAZ at DailyMed

Pharmacology for Tradename: FORTAZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teligent
FORTAZ
ceftazidime
INJECTABLE;INJECTION050578-002Jul 19, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ IN PLASTIC CONTAINER
ceftazidime sodium
INJECTABLE;INJECTION050634-003Apr 28, 1989RXYesYes► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ
ceftazidime
INJECTABLE;INJECTION050578-001Jul 19, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ
ceftazidime
INJECTABLE;INJECTION050578-003Jul 19, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
Teligent
FORTAZ
ceftazidime
INJECTABLE;INJECTION050578-004Jul 19, 1985APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Farmers Insurance
Colorcon
Cantor Fitzgerald
QuintilesIMS
Medtronic
Deloitte
Dow
UBS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot